Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Core Scientific, Inc./txCORZ · Entity 389 | Director | January 27, 2025 | January 29, 2025 |
| Strategy IncMSTR · Entity 3031 | Director | October 08, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Core Scientific, Inc./tx
Report date January 27, 2025 · Filed January 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 320,448 |
Reported balance
After 2025-01-27 transaction · row 1
1 source rowRow 1 · 2025-01-27 · Grant · Acquired 20,448 · Balance 320,448 F1: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on January 27, 2026, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on January 27, 2026, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date.
Strategy Inc
Report date October 08, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 28,406 |
Ending reported balance
After 2026-10-09 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-10-08 · Exercise / conversion · Acquired 1,400 · Balance 29,806 Row 2 · 2026-10-08 · Sale · Disposed 950 · Balance 28,856 Row 3 · 2026-10-08 · Sale · Disposed 450 · Balance 28,406 Row 4 · 2026-10-09 · Exercise / conversion · Acquired 1,350 · Balance 29,756 Row 5 · 2026-10-09 · Sale · Disposed 450 · Balance 29,306 Row 6 · 2026-10-09 · Sale · Disposed 450 · Balance 28,856 Row 7 · 2026-10-09 · Sale · Disposed 450 · Balance 28,406 |
| Director Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-05-31 | Direct | 23,450 |
Reported balance
After 2026-10-08 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-10-08 · Exercise / conversion · Disposed 1,400 · Balance 23,450 F1: The 1,400 shares exercised on October 8, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 23,450 shares pursuant to this option, 10,950 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021. |
| Director Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-05-31 | Direct | 22,100 |
Reported balance
After 2026-10-09 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-10-09 · Exercise / conversion · Disposed 1,350 · Balance 22,100 F2: The 1,350 shares exercised on October 9, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 22,100 shares pursuant to this option, 9,600 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021. |
| Series A Perpetual Strife Preferred StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 10,000 |
| Series A Perpetual Stretch Preferred StockSEC Table I · non-derivative | Direct | 29,335 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 29,335 |
| Series A Perpetual Stride Preferred StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The 1,400 shares exercised on October 8, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 23,450 shares pursuant to this option, 10,950 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
F2: The 1,350 shares exercised on October 9, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 22,100 shares pursuant to this option, 9,600 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2025 Filed Apr 24, 2025 20:12 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 500 | $335.65 | $167,825.00 |
DisclosureSEC source: 0000950170-25-058048 · ownership.xml · nonDerivative · entry 2 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,170 Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 20:12 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionClass A Common Stock | 1,700 | $17.60 | $29,916.60 |
DisclosureSEC source: 0000950170-25-058048 · ownership.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On August 7, 2024, the Issuer effected a 10-for-1 forward stock split. See Exhibit A for additional information. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 00:12 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 20,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000233 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,448 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on January 27, 2026, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 23:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 2,240 | $11.05 | $24,752.00 |
DisclosureSEC source: 0000905148-24-002553 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:21 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 2,100 | $10.10 | $21,210.00 |
DisclosureSEC source: 0000905148-24-002547 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,760 Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 2,100 | $9.90 | $20,790.00 |
DisclosureSEC source: 0000905148-24-002541 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,660 Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:29 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 7,800 | $9.28 | $72,384.00 |
DisclosureSEC source: 0000905148-24-002520 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,560 Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:57 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 5,021 | $9.68 | $48,596.25 |
DisclosureSEC source: 0000905148-24-002502 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,760 F1 · price: The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $9.595 to $9.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within such range. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 20:42 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 1,500 | $9.95 | $14,925.00 |
DisclosureSEC source: 0000905148-24-002489 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,739 Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:54 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 4,000 | $9.70 | $38,800.00 |
DisclosureSEC source: 0000905148-24-002402 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,239 Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC | Strategy Inc MSTR · Entity 3031 | GrantRestricted Stock Units · Derivative | 98 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068788 · ownership.xml · derivative · entry 4 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98 Underlying: Class A Common Stock · 98 shares Expires not disclosed F4 · security: These grants were made pursuant to the MicroStrategy Incorporated 2023 Equity Incentive Plan ("2023 Plan"), which provides for the annual automatic grant of equity awards with an aggregate fair value of $300,000 (split evenly between RSUs and options) to each non-employee director on May 31 of each year, beginning in 2023. The 2023 Plan was approved by the stockholders of MicroStrategy Incorporated at the 2023 annual meeting. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MicroStrategy class A common stock. F6 · derivative.exercise_date: These restricted stock units are scheduled to vest as to 98 shares on the first anniversary of the grant date. F6 · derivative.expiration_date: These restricted stock units are scheduled to vest as to 98 shares on the first anniversary of the grant date. F3 · balance_after: See Exhibit A. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC | Strategy Inc MSTR · Entity 3031 | GrantDirector Stock Option (Right to buy) · Derivative | 139 | $0.00 Strike: $1,524.49 | $0.00 |
DisclosureSEC source: 0000950170-24-068788 · ownership.xml · derivative · entry 3 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139 Underlying: Class A Common Stock · 139 shares Expires 2034-05-31 F4 · security: These grants were made pursuant to the MicroStrategy Incorporated 2023 Equity Incentive Plan ("2023 Plan"), which provides for the annual automatic grant of equity awards with an aggregate fair value of $300,000 (split evenly between RSUs and options) to each non-employee director on May 31 of each year, beginning in 2023. The 2023 Plan was approved by the stockholders of MicroStrategy Incorporated at the 2023 annual meeting. F5 · derivative.exercise_date: This option is scheduled to vest as to 139 shares on the first anniversary of the grant date. F3 · balance_after: See Exhibit A. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionRestricted Stock Units · Derivative | 497 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068788 · ownership.xml · derivative · entry 2 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 497 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MicroStrategy class A common stock. F2 · derivative.exercise_date: The 497 restricted stock units vested in full on May 31, 2024. F2 · derivative.expiration_date: The 497 restricted stock units vested in full on May 31, 2024. F3 · balance_after: See Exhibit A. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionClass A Common Stock | 497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-068788 · ownership.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MicroStrategy class A common stock. Read SEC document |
| May 27, 2024 Filed May 29, 2024 20:12 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 47,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001648 · form4.xml · nonDerivative · entry 2 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,239 F2 · shares: Represents an RSU grant. The RSUs will vest in full on January 23, 2025, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date. Read SEC document |
| May 27, 2024 Filed May 29, 2024 20:12 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 127,446 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001648 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,446 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on January 23, 2027, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionDirector Stock Option (Right to buy) · Derivative | 3,675 | $0.00 Strike: $121.43 | $0.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · derivative · entry 26 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,675 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The 3,675 shares exercised on March 21, 2024 pursuant to this option vested on April 30, 2018. F3 · balance_after: See Exhibit A. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 175 | $1,623.35 | $284,086.25 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 24 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 700 | $1,603.60 | $1,122,520.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 23 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 800 | $1,598.61 | $1,278,888.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 22 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 875 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,598.32 to $1,598.75, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated, any security holder of MicroStrategy Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,648.50 | $247,275.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 21 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,675 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,670.46 | $334,092.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 20 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,825 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,690.00 | $253,500.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 19 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,025 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,669.53 | $333,906.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 18 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,612.22 | $322,444.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 17 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,375 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,700.00 | $255,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 16 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,575 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,697.45 | $254,617.50 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 15 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,725 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,680.00 | $252,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 14 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,875 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,660.00 | $249,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 13 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,025 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,640.00 | $246,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 12 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,175 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 100 | $1,620.00 | $162,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 11 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,325 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 100 | $1,640.00 | $164,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 10 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,425 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,602.06 | $240,309.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 9 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,525 Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionClass A Common Stock | 3,675 | $121.43 | $446,255.25 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 8 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionDirector Stock Option (Right to buy) · Derivative | 1,425 | $0.00 Strike: $121.43 | $0.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · derivative · entry 25 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 Underlying: Class A Common Stock · 1,425 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The 1,425 shares exercised on March 20, 2024 pursuant to this option vested on April 30, 2018. The remaining 3,675 shares subject to this option vested on April 30, 2018. F3 · balance_after: See Exhibit A. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 375 | $1,406.00 | $527,250.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 7 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 250 | $1,531.54 | $382,885.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 6 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 250 | $1,417.22 | $354,305.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 5 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,470.00 | $294,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 4 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 875 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,450.00 | $290,000.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 3 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,075 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,443.64 | $216,546.00 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 2 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,275 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:36 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionClass A Common Stock | 1,425 | $121.43 | $173,037.75 |
DisclosureSEC source: 0000950170-24-035411 · ownership.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:17 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | PurchaseCommon Stock | 100,000 | $3.32 | $332,220.00 |
DisclosureSEC source: 0000905148-24-000979 · form4.xml · nonDerivative · entry 1 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.0284 to $3.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within such range. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | Exercise / conversionDirector Stock Option (Right to buy) · Derivative | 2,575 | $0.00 Strike: $121.43 | $0.00 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · derivative · entry 13 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Class A Common Stock · 2,575 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The 2,575 shares exercised on March 12, 2024 pursuant to this option vested on April 30, 2018. The remaining 5,100 shares subject to this option vested on April 30, 2018. F3 · balance_after: See Exhibit A. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 200 | $1,590.00 | $318,000.00 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 12 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,579.91 | $236,986.50 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 11 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,579.09 | $236,863.50 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 10 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 150 | $1,557.90 | $233,685.00 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 9 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 100 | $1,547.90 | $154,790.00 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 8 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,547.86 to $1,548.24, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated, any security holder of MicroStrategy Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:39 UTC | Strategy Inc MSTR · Entity 3031 | SaleClass A Common Stock | 275 | $1,542.13 | $424,085.75 |
DisclosureSEC source: 0000950170-24-030830 · ownership.xml · nonDerivative · entry 7 Patten Jarrod M · CIK 0001309191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.